A Case-control Study of the Efficacy of a New Serogroup A Meningococcal Conjugate Vaccine (MenAfriVac) in Mali and Niger.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 19 Feb 2013
At a glance
- Drugs Meningococcal vaccine group A conjugate (Primary)
- Indications Meningococcal group A infections
- Focus Therapeutic Use
- 19 Feb 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 12 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Mar 2011 New trial record